March 1-5, 2025
Boston Convention and Exhibition Center
Boston, Massachusetts, USA
HOME
ATTEND
CONFERENCE
EXPOSITION
EXHIBIT

Life Sciences

VIDEOS ARTICLES INTERVIEWS

Videos

loading videos
Loading Videos...

Articles

Introduction Medical professionals are under an increasing amount of pressure to provide early diagnoses and more efficacious treatments with fewer side effects. There is also a demand for more information about disease risk and prophylactic options. Technology is powering developments in biomedicine, with advances in computing power and imaging techniques...
Introduction Medicinal products derived from a biological source are commonly referred to as biotherapeutics or biologicals. They are typically proteins or polypeptides of >40 amino acids whose active components are constructed using biotechnology. A range of structural modifications are made to optimize the desirable functional characteristics of the target proteins...
Introduction: The structure of DNA was discovered over 60 years ago, yet many mysteries remain on how our genome functions. In order to understand what the genome means we need to know, not just its sequence, but how this relates to phenotype. Our genome is over three billion bases long,...

Interviews

An interview with Amanda Hummon PhD, Associate Professor from Ohio State University, discussing how mass spectrometry can be used to analyze the proteome and how this can help with the study of human disease. How is mass spectrometry used to study the proteome? Mass spectrometers are essentially very expensive weighing...
Dr. Chad Mirkin, Director of International Institute for Nanotechnology talks to News-Medical Life Science about the use of spherical nucleic acids (SNAs) in vaccinations and treatments for disease, and what they show about the importance of structure in pharmaceutical development. What are spherical nucleic acids (SNAs)? Spherical nucleic acids (SNAs)...
An interview with Livia Eberlin, Assistant Professor at the University of Texas at Austin, discussing the development of mass-spectrometry based techniques for cancer diagnosis and improved clinical outcomes. Why is there a need for alternatives to cytological analysis in the field of oncology? Within the context of cancer surgeries, the...

 

 

 

Back to Top